Effects of Epalrestat on Diabetic Gastroparesis and Autonomic Neuropathy

ZHOU Lin,GAO Fang,XUE Yao-ming,BIAN Yan-fang
DOI: https://doi.org/10.3969/j.issn.1007-7669.2007.02.015
2007-01-01
Abstract:AIM:To observe the effects of epalrestat in treating diabetic gastroparesis (DGP) and auto-nomic neuropathy. METHODS; Sixteen patients with DGP (M10, F6, age (51±s 13) a), diabetic courses (12±5) a were selected. All patients were treated with epalrestat 50 mg, po, tid for 12 wk. Heart rate variability (HRV) and electrogastrogram (EGG) were measured before and after treatment, and therapeutic effect on clinical syndromes was assessed. RESULTS:EGG were significantly changed after treatment mainly manifested as increase of proportional dominant frequency (PDF) for (0.8±0.8) cpm and strengthening of proportional dominant amplitude (PDP) for (83±32) |xV. The low frequency (LF) and the ratio of LF/HF were decreased by (38±16) ms2 and 1.8±0.4, and the other parameters of HRV were increased. All parameters were improved significantly after treatment (P 0.01) . Symptoms of major patients were improved, with rare adverse reactions. CONCLUSION:Epalrestat can enhance gastric motility and improve dysfunction of the regulation of vagal and sympathetic nerves system. It is safe and effective in treatment of DGP.
What problem does this paper attempt to address?